
Archive
Hot Topics of the Day are picked by experts to capture the latest information and publications on public health genomics and precision health for various diseases and health topics. Sources include published scientific literature, reviews, blogs and popular press articles.
Cancer incidence, patterns, and genotype–phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study
KC Andrade et al, Lancet Oncology, November 12, 2021
(Posted: Nov 13, 2021 6AM)
Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis.
Kratz Christian P et al. JAMA oncology 2021 10
(Posted: Nov 02, 2021 6PM)
Cancer killed my mother, brother, and sisters. As the longest-living member of my family, I was determined to understand why
L Ingrassia, Stat News, July 28, 2021
(Posted: Jul 28, 2021 10AM)
Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
T Frebourg et al, EJHG et al, May 26, 2020
(Posted: May 27, 2020 9AM)
Cancer at Baseline Screening in Patients With Li-Fraumeni Syndrome
ASCO Post, August 4, 2017
(Posted: Aug 07, 2017 9AM)
NCI study shows feasibility of cancer screening protocol for Li-Fraumeni syndrome patients
Science Mag, August 3, 2017
(Posted: Aug 07, 2017 9AM)
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.
Kratz Christian P et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 06 (11) e38-e45
(Posted: Aug 03, 2017 8PM)
Surveillance of Dutch Patients With Li-Fraumeni Syndrome
The LiFe-Guard Study
JMWJ Rujis et al, JAMA Oncology, August 3, 2017
(Posted: Aug 03, 2017 8PM)
Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging
A Meta-analysis
ML Ballinger et al, JAMA Oncology, August 3, 2017
(Posted: Aug 03, 2017 8PM)
Surveillance in Germline TP53 Mutation Carriers Utilizing Whole-Body Magnetic Resonance Imaging
ML Ballinger et al JAMA Oncology, August 3, 2017
(Posted: Aug 03, 2017 8PM)
Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort
PL Mi et al, JAMA Oncology, August 3, 2017
(Posted: Aug 03, 2017 8PM)
Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition.
Valdez Jessica M et al. British journal of haematology 2017 Feb (4) 539-552
(Posted: Mar 22, 2017 10AM)
Should Genetic Testing be Offered for Children? The Perspectives of Adolescents and Emerging Adults in Families with Li-Fraumeni Syndrome.
Alderfer Melissa A et al. Journal of genetic counseling 2017 Mar
(Posted: Mar 22, 2017 10AM)
Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H Carriers With Li Fraumeni Syndrome
MN da Cruz Formiga et al, JAMA Oncology, January 19, 2016
(Posted: Jan 20, 2017 1PM)
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.
Bougeard Gaëlle et al. J. Clin. Oncol. 2015 May 26.
(Posted: Jun 11, 2015 8AM)
Surveillance recommendations for patients with germline TP53 mutations.
Ballinger Mandy L et al. Curr Opin Oncol 2015 Jul (4) 332-7
(Posted: Jun 11, 2015 8AM)
Stomach (Gastric) Cancer Prevention (PDQ®)–Health Professional Version
(Posted: Jan 11, 2014 11AM)
Li-Fraumeni syndrome
From NCATS Genetic and Rare Diseases Information Center
(Posted: Jan 01, 2011 0AM)
Disclaimer: Articles listed in Hot Topics of the Day are selected by Public Health Genomics Branch to provide current awareness of the scientific literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the Clips, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: